FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Health data show that COVID-19 still surpasses all other infectious respiratory illnesses as a cause of severe illness, ...

The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...

The U.S. Food and Drug Administration on Friday approved the first flu vaccine that comes in the form of a nasal spray and ...

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007 ... Nationally, flu vaccination ...

The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...

With the peak flu season often occurring during December and January and even into February, Dr. Sharon Nachman, Chief of the ...